Ronald Hans Wilmar Lorijn

Ronald Hans Wilmar Lorijn

Chief Executive Officer chez NeuExCell Therapeutics, Inc.

73 ans
Health Technology
Health Services
Consumer Services

Profil

Ronald Hans Wilmar Lorijn currently works at NeuExCell Therapeutics, Inc., as Chief Executive Officer and nLife Therapeutics SL, as Director.
Dr. Lorijn also formerly worked at Amsterdam Molecular Therapeutics (AMT) Holding NV, as Chief Executive Officer, uniQure NV, as Chief Executive Officer, Esperite NV, as Non Executive Director in 2010, Centocor, Inc., as Chief Medical Officer, Pepscan Therapeutics BV, as Member-Supervisory Board from 2012 to 2016, and Janssen Biologics BV, as Chief Medical Officer.
Dr. Lorijn received his doctorate degree from Radboud University Nijmegen.

Postes actifs de Ronald Hans Wilmar Lorijn

SociétésPosteDébut
Director/Board Member -
Chief Executive Officer -
Tous les postes actifs de Ronald Hans Wilmar Lorijn

Anciens postes connus de Ronald Hans Wilmar Lorijn

SociétésPosteFin
Director/Board Member -
Chief Executive Officer 01/02/2009
UNIQURE N.V. Chief Executive Officer 01/02/2009
Chief Tech/Sci/R&D Officer -
Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Ronald Hans Wilmar Lorijn

Formation de Ronald Hans Wilmar Lorijn

Radboud University Nijmegen Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Ronald Hans Wilmar Lorijn

Relations

10

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
UNIQURE N.V.

Health Technology

Entreprise privées7

Health Technology

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Ronald Hans Wilmar Lorijn